Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Find out what the best credit card points redemptions are. Maximize your rewards and make informed decisions for your finances.
18,746 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Wells Fargo and Jefferies boosted ONEOK on Wednesday, citing a structural shift in energy demand tied to Iran-related...
A Florida magistrate recommends dismissing the Zea antitrust lawsuit against the NAR and MLSs, warning the complaint ...
Intel and AMD delivered contrasting Q4 results, highlighting divergent paths: Intel grappling with foundry losses ami...
Anchorage Digital Bank announced a regulatory milestone, bringing Tron inside the U.S. regulatory perimeter. The move...
When a company’s top legal officer discloses a stock sale, investors pay attention. This guide explains how to read i...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
As 2026 begins, Tesla faces pressure on deliveries while BYD battles domestic slumps but advances fast charging and o...
When leaders sell stock alongside stronger earnings, investors should look beyond headlines. This guide breaks down i...
A major national poll released this week reveals broad dissatisfaction with the economy, a finding that may influence...
North Korea’s Foreign Ministry rejected cyber theft accusations as 'absurd slander,' arguing the claims are political...
Apple reports strong Q2 2026 results, led by iPhone demand and Services, while signaling a shift toward ambient AI th...